Talking Precision Medicine

• Anna Berkenblit & Sudheer Doss, PanCAN | On a mission to beat an ignoble killer: pancreatic cancer | TPM podcast #45

  Today’s guests are Anna Berkenblit, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss, Chief Business Officer at PanCAN. The Pancreatic Cancer Action Network is the leading organization dedicated to advancing progress against pancreatic cancer. It empowers patients and caregivers, drives early detection strategies, and revolutionizes the development of advanced and personalized treatments.TPM E45 highlights >⁠⁠⁠⁠⁠⁠⁠⁠Episode 45 links:Anna Berkenblit on LinkedInSudheer Doss on LinkedInPanCANFor access to data through PanCAN’s SPARK platform, please visit: PanCAN.org/sparkFor more information, contact PanCAN Patient Services with questions about any type of pancreatic cancer – we are here to help.

  --------  

  46:10
• Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44

  Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.It has become an iconic name in the field of artificial intelligence for drug discovery.TPM E44 highlights >⁠⁠⁠⁠⁠⁠⁠Episode 44 links:Najat Khan on LinkedInRecursion

  --------  

  38:35
• Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43

  What a pleasure to welcome today’s guest, Ryan Fukushima, chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days, he is also CEO of Pathos AI, a biotech company using real world data and AI to develop true precision medicines. I don’t know how he juggles it all, but unless you’ve been hiding out these last few years, Tempus has become a household name in our industry, completing a highly successful IPO last year. But no need to take my word for it, come on in and have a listen!TPM E43 highlights >⁠⁠⁠⁠⁠⁠Episode 43 links:Ryan Fukushima on LinkedIn⁠⁠Tempus AI⁠⁠Pathos⁠⁠Tempus announces multi-year collaboration with Genialis

  --------  

  43:19
• The journey to the top of life sciences technology: a lifetime of listening and learning | Talking Precision Medicine #42

  Today my guest is Joydeep Goswami, newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as we discuss his remarkable career and lessons learned at each step of the way. Come on in and have a listen. Episode 42 links: ⁠⁠⁠⁠⁠⁠⁠TPM E42⁠⁠⁠ for highlights and links from this episode >⁠⁠⁠⁠⁠⁠ Tempus Announces a Collaboration With Genialis Genialis’ Upcoming Events

  --------  

  47:34
• The view from 30,000: Healthcare & life science AI in the cloud | Talking Precision Medicine #41

  This episode features a conversation with Shweta Maniar, who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intelligence has gone from the stuff of hype and fairy tale to powerful and ubiquitous tools for all aspects of R&D and healthcare delivery. Google has been central to this sea change. I discuss with Shweta how her organization helps make these advanced capabilities available to the masses, and so much more. Join us! Episode 41 links: ⁠⁠⁠⁠⁠⁠⁠TPM E41⁠⁠⁠ for highlights and links from this episode >⁠⁠⁠⁠ Genialis™ Supermodel Happy Holidays Genialis' Upcoming Events Genialis on LinkedIn

  --------  

  37:10

Weitere Wissenschaft Podcasts

Trending Wissenschaft Podcasts

Über Talking Precision Medicine